Myriad Genetics | MYGN - Ebitda


Myriad Genetics reported $10.3M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Agilent USD 466M 5M Jun/2025
Becton, Dickinson and Co. USD 2.15B 674M Sep/2025
Bio-Rad Laboratories USD 467.2M 372.2M Jun/2025
Bruker USD 128.1M 27.1M Jun/2025
Danaher USD 2.13B 252M Dec/2025
Exact Sciences USD 135.42M 2.8M Sep/2025
Hologic USD 330.4M 16.6M Dec/2025
Illumina USD 332M 12M Sep/2025
J&J USD 9.52B 389M Sep/2025
Mettler Toledo International USD 322.64M 26.75M Sep/2025
Myriad Genetics USD 10.3M 4.2M Sep/2025
Quest Diagnostics USD 561M 9M Sep/2025
Quidel USD 177.1M 70.3M Sep/2025
Repligen USD 35.93M 3.75M Sep/2025
Revvity USD 248.91M 48.52M Dec/2025
Standard Biotools USD -16.54M 2.26M Sep/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
Veracyte USD 39.73M 3.96M Sep/2025
Waters USD 295.14M 18.87M Sep/2025